Journal
New England Journal of Medicine
Publication Date
3-16-2023
Volume
388
Issue
11
First Page
1002
Last Page
1014
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2213614
Acceptable Secondary Publication – Plain Language Summary
Rights and Permissions
Rodriguez-Otero P, Ailawadhi S, Arnulf B, Patel K, Cavo M, Nooka AK, Manier S, Callander N, Costa LJ, Vij R, Bahlis NJ, Moreau P, Solomon SR, Delforge M, Berdeja J, Truppel-Hartmann A, Yang Z, Favre-Kontula L, Wu F, Piasecki J, Cook M, Giralt S. Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma. N Engl J Med. 2023 Mar 16;388(11):1002-1014. doi: 10.1056/NEJMoa2213614. Copyright © 2023 Massachusetts Medical Society. Reprinted with permission.
Recommended Citation
Rodriguez-Otero, Paula; Vij, Ravi; and et al., "Ide-cel or standard regimens in relapsed and refractory multiple myeloma." New England Journal of Medicine. 388, 11. 1002 - 1014. (2023).
https://digitalcommons.wustl.edu/oa_4/2337
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
